Centre tells Delhi HC: Zydus Cadila’s COVID vaccines for children may be available in near future
Pharmaceutical major Zydus Cadila’s COVID-19 vaccine may be available in the near future for children in the age…
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre’s Covaxin price
Hyderabad-based vaccine maker Bharat Biotech on Tuesday said the current supply price of its Covid-19 vaccine Covaxin to…
COVID-19: Government extends help to Indian students studying abroad now stuck in country
The Ministry of External Affairs (MEA) on Saturday asked the Indian students studying abroad to contact their OIA-II…
Clinical trial of Bharat Biotech’s Covaxin on children begins at AIIMS Patna
The clinical trial of Bharat Biotech’s COVAXIN on children began at AIIMS Patna. All 15 kids who voluntarily…
Students heading to universities abroad can get vaccines at walk-in centres in Mumbai
People above 45 years age can now get their first as well as the second dose of Covishield…
Delhi high court refuses to stay Covaxin clinical trial on children aged 2-18
The Delhi high court on Wednesday refused to grant an interim stay on the clinical trial of Covaxin…
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of…
Covaxin trials approved in children between 2 and 18 years
The approval has been granted for testing the vaccine on children between 2 and 18 years of age.…
Manish Sisodia: Bharat Biotech says can’t give additional Covaxin doses to Delhi
Bharat Biotech has informed the Delhi government that it cannot provide “additional” Covaxin doses to the national capital,…
Karnataka to get 2 crore COVID-19 vaccine doses through global tender
The Karnataka government on Tuesday decided to procure two crore COVID-19 vaccine doses through global tender. Deputy Chief…